Neuro-Oncology Reviews

Volume 28 Number 7
10 March 2026

Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 7, 10 March

Farias de Alvarenga KA, Oliveira de Araújo J, Rezende da Silveira M, Silva NS, Coelho MR, Pimentel JA, Pereira Dos Reis A, Cappellano AM, Mançano BM, D'Almeida Costa F, Martins FD, Bellas GO, Teixeira GR, Gomy I, Gregianin LJ, Okamoto OK, Campregher PV, Camargo R, Ferman SE, Valera ET; Brazilian Committee of Precision Medicine in Pediatric Oncology (BC-PMPO) — the Brazilian Society of Pediatric Oncology (SOBOPE).
Precision diagnosis and therapy for pediatric central nervous system tumors: consensus from the Brazilian Society of Pediatric Oncology (SOBOPE).
Lancet Reg Health Am. 2026 Mar 2;57:101422. doi: 10.1016/j.lana.2026.101422. PMID: 41808847. ˍ

Khasraw M, Pristo E, Stupp R.
20 years of the Stupp protocol: confronting stagnation in glioblastoma therapy.
Lancet Oncol. 2026 Mar 2;27(3):277-280. doi: 10.1016/S1470-2045(25)00705-3. PMID: 41785890˰ ˍ

Kurdi M, Kabli A, Alkhotani A, Alkhotani A, Bokhari R, Jastaniah Z, Amjad R, Althoukhi H, Alsinani T, Alamoudi H, Baeesa S.
Impact of corticosteroid administration on glioblastoma progression before and after adjuvant treatments: recent updates on contradictory findings and mechanistic interactions.
Front Oncol. 2026 Mar 2;16:1774736. doi: 10.3389/fonc.2026.1774736. PMID: 41847699. ˍ

Wells J, Gupta A.
CAR-T cell therapy for pediatric solid tumors: armored CAR-T cells and beyond.
Cancer Metastasis Rev. 2026 Mar 2;45(1):10. doi: 10.1007/s10555-026-10317-2. PMID: 41770377. ˍ

Yenidogan I, Tabori U, Das A.
Immune checkpoint inhibitors in pediatric central nervous system tumors: biology, clinical experience, and translational pathways to precision immunotherapy.
J Neurooncol. 2026 Mar 2;177(1):27. doi: 10.1007/s11060-026-05491-w. PMID: 41772324. ˍ

Breu J, Baumann B, Sa JK, Berghoff AS, Preusser M, Nenning KH, Woehrer A.
Evolving landscape of glioblastoma research : A 75-year bibliometric study on survival, treatment and gender in authorship.
Wien Klin Wochenschr. 2026 Mar 10. doi: 10.1007/s00508-026-02725-9. PMID: 41807741. ˍ

Wang Y, Jia W, Chai R, Xia W, Wang L, Qiu X, Liu Y, Zhang W, Kang C, Wang Y, Liu Y, An S, Sun T, Zhang Y, Liu Y, Pang B, Li N, Zhang Z, Yan H, Zhang Y, Chang Y, Fan W, Wang L, Sun B, Jiang T; Chinese Glioma Cooperative Group (CGCG).
The CGCG response assessment criteria for spinal cord gliomas.
Cancer Lett. 2026 Mar 6;646:218415. doi: 10.1016/j.canlet.2026.218415. PMID: 41796847˰ ˍ

Shlobin NA, Hasner MC, Karschnia P, Widhalm G, Petrescu GED, Schucht P, Picart T, Neidert MC, Gempt J, Grossman R, Jakola AS, Jenkinson MD, Goldbrunner R, Weller M, Duerinck J, Broekman MLD.
Ethical considerations in randomization for neurosurgical oncology trials: A scoping review.
Neurooncol Pract. 2025 Aug 16;13(1):3-13. doi: 10.1093/nop/npaf085. PMID: 41798128˰ ˍ

Riaz I, Ali EA, Sial M, Alam MM, Khan C, Khan S, Riaz M.
Efficacy and safety of awake craniotomy versus general anesthesia for glioma resection: A systematic review.
Surg Neurol Int. 2026 Feb 6;17:66. doi: 10.25259/SNI_1102_2025. PMID: 41783186. ˍ

Yi J, Wen J, Wang N, Yuan M, Leng H, Chen H.
Influence of diabetes on survival of patients with glioma: a meta-analysis.
Front Endocrinol (Lausanne). 2026 Feb 12;17:1667242. doi: 10.3389/fendo.2026.1667242. PMID: 41767392. ˍ

Padilla F, Arvanitis C, Bollard CM, Gallus M, De Groot J, Klein RS, Ransohoff RM, Sonabend AM, Okada H.
Focused ultrasound-enhanced cell therapy for brain tumors: Summary of roundtable discussions.
Neurooncol Adv. 2026 Feb 14;8(1):vdag026. doi: 10.1093/noajnl/vdag026. PMID: 41773179. ˍ

Li Y, Qin X, Liang C, Wang L.
Progress in the research and development of oncolytic virus therapies.
Front Pharmacol. 2026 Feb 19;17:1751206. doi: 10.3389/fphar.2026.1751206. PMID: 41800095. ˍ

Gonzales-Portillo D, Vashi B, Bains Williams K, Cervantes J.
Metformin Renders Survival Advantage to Patients with Glioblastoma Multiforme.
Neurol Int. 2026 Feb 24;18(3):40. doi: 10.3390/neurolint18030040. PMID: 41893042. ˍ

Heggebø LC, Johannessen TA, Magelssen H, Sprauten M, Blakstad H, Brekke J, Goplen D, Marienhagen K, Solheim TS, Bjorland L, Brandal P.
Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.
Clin Transl Radiat Oncol. 2026 Feb 25;58:101140. doi: 10.1016/j.ctro.2026.101140. PMID: 41798870. ˍ

Wu F, Yang Y, Wang Z, Jiang R, Wu T, Yu T, Wang P.
Gliosarcoma of the right cerebellar hemisphere and parahippocampal region: A case report and literature review.
Oncol Lett. 2026 Feb 25;31(4):147. doi: 10.3892/ol.2026.15500. PMID: 41797885. ˍ

Bedrosian TA, Wong M, Heinzen EL, Deneen B, Christian-Hinman CA.
Merritt-Putnam Symposium | Tumor-Associated Epilepsy and Epilepsy-Associated Tumors: Exploring the Bidirectional Crosstalk Between Tumors and Seizures.
Epilepsy Curr. 2026 Feb 26:15357597261418332. doi: 10.1177/15357597261418332. PMID: 41768595. ˍ

Chen HC, Wong ET, Sarangi S, Elinzano H, Kuburich NA, Mani SA, Ali R, Cielo D, Svokos KA, Sampath P, Malik AN, Lee CK, Doberstein CE, Lawler SE, Seyhan A, El-Deiry WS, Chen CC.
Tumor antigen only (TAO) vaccine platforms for glioblastoma therapeutics: a systematic review of evidence from clinical trials.
EClinicalMedicine. 2026 Feb 26;93:103774. doi: 10.1016/j.eclinm.2026.103774. PMID: 41783089. ˍ

Kisiel S, Pawlik M, Niemcewicz WJ, Janicki W, Świerczyńska J, Romanczuk K, Zdanowski R, Borkowska A.
From Cerebrovascular Injury to Brain Cancer: The Role of Blood-Brain Barrier Dysfunction.
Biomedicines. 2026 Feb 26;14(3):511. doi: 10.3390/biomedicines14030511. PMID: 41898158. ˍ

Kordyukova MY, Bulgakov TK, Sorokina MA, Kudryashova OM, Abakumova TO, Meshcheryakova VI, Grigoriev IV, Senko IV, Shevchenko EK, Belousov VV.
Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.
Int J Mol Sci. 2026 Feb 26;27(5):2207. doi: 10.3390/ijms27052207. PMID: 41828436. ˍ

Wang P, Liu W, Zhou C.
Mapping knowledge landscapes and emerging trends in artificial intelligence in glioblastoma: A bibliometric analysis.
Digit Health. 2026 Feb 26;12:20552076261428356. doi: 10.1177/20552076261428356. PMID: 41767867. ˍ

Zhao H, Jiang Q, Wang Q, Wang Z, Huang Y, Lei T.
Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy.
Cells. 2026 Feb 26;15(5):409. doi: 10.3390/cells15050409. PMID: 41827842. ˍ

Hayat MA, Yu S, Tao G, Ghani MU, Hu J.
Chimeric antigen receptor T cell therapy for glioblastoma: overcoming current barriers and strategies to enhance efficacy for therapeutic implications.
Biochem Pharmacol. 2026 Feb 27;248:117851. doi: 10.1016/j.bcp.2026.117851. PMID: 41765112˰ ˍ

Salmeron-Moreno K, Papisetty K, Kim CD, McCaffery T, Kashlan R, Theodore J, Kim JM, Buclez J, Duggireddy H, Maldonado J, Guerrero-Cázares H, Pradilla G, Garzon-Muvdi T.
Neuro-Oncological Perspectives on Cancer Stem Cell Biology in Glioblastoma: Implications for Resection, Recurrence, Targeted Therapy, and Other CNS Tumors.
Cells. 2026 Feb 27;15(5):413. doi: 10.3390/cells15050413. PMID: 41827847. ˍ

Mishra P, Gupta P, Markowska A, Ghavami S, Markowski J, Łos MJ.
Advancements in Drug Delivery Systems in Glioblastoma Therapy.
Int J Mol Sci. 2026 Feb 28;27(5):2298. doi: 10.3390/ijms27052298. PMID: 41828518. ˍ